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The race against the “septic shark”
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Abstract
Great white sharks are responsible for about 10 cases of death annually worldwide, as compared with millions of
deaths caused by sepsis. However, the basic principles of avoiding shark attacks and fighting sepsis seem to be
similar: avoidance, attention, and speed, if necessary. The present review discusses the current status of the
systemic inflammatory response syndrome (SIRS) criteria, which are actually content for discussion because of their
low specificity. Current data suggest that one in eight patients with severe sepsis does not fulfill the SIRS criteria
and is consequently missed, and therefore the calls for new definitions of sepsis are getting louder. Furthermore,
the need for early treatment of sepsis and fast admission to an intensive care unit (ICU) with experienced stuff is
reviewed as well as the early and appropriate initiation of therapy, namely antibiotic and volume therapy. A key
feature is the analysis of the studies from the so-called “Sepsis Trilogy” (ProCESS, ARISE, and ProMiSe studies), with
a focus on the status of early goal-directed therapy (EGDT). The authors of the “Sepsis Trilogy” concluded that
there is no benefit regarding survival in septic patients by using EGDT as compared with standard therapy.
However, the low mortality of the control groups within the “Sepsis Trilogy” studies as compared with the Rivers et
al. study from 2001 leads to the conclusion that there has been an improvement in the therapy of septic patients,
most probably due to the early initiation of therapy as a kind of “standard” in sepsis therapy. Finally, the
phenomenon of a “large trial disease” is discussed, exemplary in a trial which investigated the maintenance of the
“right” mean arterial pressure in sepsis patients. Even if the result of a large randomized trial might be that there is
no difference between two study groups, the real exercise is to identify the patient collectives who might benefit
or experience harm due to an intervention. In summary, as compared with swimming in dangerous waters, high
attention is needed in handling septic patients. Once an attack has occurred, speed is of utmost importance (i.e.,
initiation of therapy and admission to the ICU) because it appears logical that time is critical in septic patients This
may have resulted in the implementation of early (goal-directed) treatment as a “standard” in the treatment of
sepsis with significant improvement in survival.
Now is no time to think of what you do not have. Think
of what you can do with what there is.
Ernest Hemingway (The Old Man and the Sea, 1952).
Great white sharks are responsible for about 100
unprovoked attacks on human beings and 10 cases of
death annually worldwide [1]. These animals are excel-
lent and fast swimmers with a swim speed of about
40 miles/hour [2]. To minimize the risk of potentially
deadly contact with a great white shark, one should
address three basic principles: avoidance, attention, and
speed, if necessary.
Sepsis and septic shock are responsible for millions of
deaths every year [3]. Despite progress in improving
outcome, the number of sepsis treatments has signifi-
cantly increased in the last decade [4]. Interestingly, the
key principles in fighting sepsis have some similarities
with the principles of minimizing shark attacks; that is,
prevention (avoidance), focus on the best treatment
algorithms (attention), and timely correction of the
underlying problem (speed).
Avoidance and prophylaxis of sepsis represent very
important aspects to reduce the global burden of sepsis.
In this context, awareness and education campaigns
involving professional societies, the World Health Orga-
nization, and politicians that highlight the importance of
hygiene and microbiology are very important measures.
After the consensus conference of the American Col-
lege of Chest Physicians (ACCP) and the Society of
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Critical Care Medicine (SCCM) defined criteria for
systemic inflammatory response syndrome (SIRS) and
sepsis in 1992, these criteria have been used for diagno-
sis over more than two decades. Notably, Jean-Louis
Vincent mentioned in 1997 [5] that the SIRS criteria,
although highly sensitive, are of low specificity and
therefore potentially misleading in making the right
diagnosis. In this context, it was highlighted that two-
thirds of ICU patients, as well as a high number of regu-
lar ward patients, actually meet the SIRS criteria. Impor-
tantly, these criteria neither take into account the
underlying pathophysiology nor the severity of the
inflammatory response [5].
Recently, Bellomo et al. [6] investigated the validity and
sensitivity of the SIRS criteria in a retrospective analysis
that included more than 100,000 patients over the last
14 years. The authors analyzed patients with infection
and organ dysfunction and classified them as “SIRS-
positive severe sepsis” (87.9%) and “SIRS-negative severe
sepsis” (12.1%). Based upon this evaluation, it appears
that approximately one in eight patients does not show
the SIRS criteria even though they are suffering from
septic shock. As expected, patients with “SIRS-negative
severe sepsis” had a lower (but still relevant) mortality
when compared with the “SIRS-positive” patients, under-
lining the risk of missing the right diagnosis in these
patients [6]. This, in turn, indicates that the SIRS criteria
in their current from are of limited use and may even be
dangerous. Meanwhile, the calls are getting louder for
the need for new definitions of SIRS and sepsis. In this
regard, it has been proposed to better define sepsis as “a
systemic response to infection with the presence of some
degree of organ dysfunction” [7].
Another aspect of “attention” that goes along with
early diagnosis of sepsis is the fast identification of the
underlying problem, therefore prompting initiation of
appropriate therapy. It appears to be logical that experi-
enced intensive care physicians are more skilled in mak-
ing the right diagnosis and initiating the best treatment
of a septic shock as compared with physicians with little
intensive care experience. This implies that patients suf-
fering from a systemic inflammation may profit from an
early (e.g., postoperative) admission to the ICU as com-
pared with no or delayed admission. Furthermore, early
ICU admission may help to prevent complications (due
to disease progression), collateral damage, and costs.
In this regard, it is important to note that several trials
in critically ill patients provided evidence that an early
intervention and admission to the ICU significantly
improved patient outcome [8,9].
One option to improve patients’ care might be the
implementation of a “sepsis intervention team” (SIT), simi-
lar to a shock team in the emergency department. The
SIT of a hospital could be a group of ICU-experienced
physicians and special nurses with the mission to provide
early diagnosis and initiate effective and adequate therapy
for patients suffering from sepsis as fast as possible. As a
hypothesis, early admission and therapy might also result
in early discharge from the ICU, which could finally help
to increase the overall ICU capacity. However, this
assumption needs to be verified by future in-depth
analyses.
A consequence of the early detection of sepsis and fast
admission to the ICU should be timely initiation of the
appropriate therapy. According to the current guidelines
of the Surviving Sepsis Campaign (SSC) [10], effective
antimicrobial therapy should be initiated within the first
hour after diagnosis. The dimension of time in this con-
text has been investigated by –among others–Kumar
et al. [11], who reported an increase in mortality of 7.6%
per hour delay in effective antibiotic therapy in hypoten-
sive septic patients. Furthermore, the authors noticed in
their retrospective study that only 50% of patients
received effective antimicrobial therapy within the criti-
cal first 6 hours. In another study, Gaieski et al. [12]
demonstrated a significant increase in mortality of
septic shock patients, who received delayed appropriate
antibiotic therapy more than 1 hour after triage. This
implies that both time and the choice of the right anti-
biotic therapy are of utmost importance for patients suf-
fering from septic shock. The SSC guidelines do not
recommend special antibiotics, but the choice of an
effective compound is recommended under considera-
tion of all possible pathogens as well as their ability to
penetrate tissue [10]. This all leads to the conclusion
that the most important aspect concerning the antibiotic
treatment of patients with septic shock is a fast initia-
tion of the most effective and appropriate compound.
Supportive therapy represents another cornerstone in
the fight against sepsis. In this regard, the choice of the
“right” infusion solutions and vasopressor agents are of
importance. The concept of early hemodynamic optimi-
zation is recommended by the SCCM guidelines [13].
This is, at least in part, related to the report of Rivers
et al. [14] indicating significant improvement of survival
in patients who received early goal-directed therapy
(EGDT) as compared with conventional hemodynamic
management. After this trial was published in 2001,
EGDT became a “solid rock” in sepsis therapy for more
than a decade. However, the concept of EGDT was
heavily challenged after the Protocolized Care for Early
Septic Shock (ProCESS) study was published in May
2014. The ProCESS Investigators randomized 1341
patients with sepsis into “protocol-based EGDT”, “proto-
col-based standard care”, and “usual care” [15]. Interest-
ingly, there was no significant difference between groups
regarding the primary endpoint; that is, 60-day mortality
(protocol-based EGDT: 21%, protocol-based standard
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therapy: 18.2%, usual care: 18.9%; each p >0.3). Further-
more, the authors reported no significant differences in
important secondary outcome variables such as need for
organ support, 90-day mortality, and 1-year mortality [15].
A few months later, the Australian Resuscitation In
Sepsis Evaluation (ARISE) study was published. This trial
was designed to compare the effects of EGDT versus
usual care in 1600 patients with early septic shock
regarding all-cause mortality after 90 days [16]. Again,
there were no significant differences among groups con-
cerning 90-day mortality (EGDT: 18.6%, usual care:
18.8%; p = 0.90). Secondary and tertiary outcome para-
meters included hospital length of stay, need for and
duration of organ support, 28-day and 60-day mortality,
as well as adverse events. Patients allocated to the EGDT
group were more likely to receive vasopressor agents
(66.6% vs. 57.8%), blood transfusions (13.6% vs. 7.0%),
and dobutamine (15.4% vs. 2.6%; each p <0.001) [16].
The third publication from this “sepsis trilogy” was the
Protocolized Management in Sepsis (ProMiSe) study. This
randomized controlled trial from the United Kingdom
included 1260 patients with early septic shock and investi-
gated the effects of EGDT vs. usual care on all-cause
90-day mortality. Secondary endpoints included the
Sequential Organ Failure Assessment (SOFA) score at
6 and 72 hours, ICU length of stay, need for organ sup-
port, and quality of life [17]. Once again, there was no sig-
nificant difference regarding 90-day mortality between the
EGDT and the usual care groups (29.5% vs. 29.2%, relative
risk = 1.01; p = 0.90). Concerning the secondary outcome
measurements, patients randomized to the EGDT group
had a significantly higher SOFA sore at 6 hours, received
more advanced cardiovascular support, and had a longer
length of stay in the ICU when compared with the usual
care group (each p <0.05) [17].
Based upon the results of these studies, the authors
concluded that protocolized EGDT did not improve out-
come in patients suffering from sepsis [15-17]. However,
this conclusion should be interpreted with caution to
avoid a potentially dangerous misinterpretation. In this
context, it is important to note that the mortality rates
of the control groups in the ProCESS, ARISE, and Pro-
MiSe studies were much lower as compared with the
Rivers et al. study 13 years earlier, in which the control
group experienced a hospital mortality of 46.5% [14]
(Figure 1 and Table 1). So how can we explain a drop
in mortality of 27.6% (or more) within 13 years? The
most logical explanation is effective early intervention in
the treatment of all sepsis patients over the last years,
which most probably also affected the mortality in the
control groups of the referenced trials [15-17].
Time is critical from physiological, medical, and logi-
cal points of view. Early hemodynamic stabilization
obviously became the new standard of care, which may
have contributed to the significant reduction of mortal-
ity during the last decade. This could be interpreted as
an important step forward in modern medicine. How-
ever, why are the mortality rates between the EGDT
and control groups of the sepsis trilogy trials so similar
(see Table 1)? In this regard, one may speculate that
there is a threshold in supportive sepsis therapy and
EGDT, where the effects of this concept are already
maximized so that no further improvement may be
achieved. Whether this assumption is true, or other con-
cepts might provide further benefit for the septic
patient, needs to be elucidated in future clinical trials.
Vincent and De Backer [18] nicely summarized the
four phases in the treatment of shock: salvage, optimiza-
tion, stabilization, and de-escalation (SOS-D). This con-
cept, which has also been described by Hoste et al. in a
slightly modified version, focuses on the clinical phases
of shock from the initial “Salvage” or “Rescue” phase
(where maintenance of a life-saving blood pressure with
bolus infusion of fluids is recommended) until the
“De-Escalation” phase (where a negative fluid balance
should be achieved) [18,19]. Whether these concepts
provide a benefit for the patient has likewise to be clari-
fied. However, the idea to rapidly adapt fluid therapy to
the respective pathophysiological phases of shock
appears to be logical and may represent one of the cru-
cial determinants in fighting septic shock (i.e., a timely
and rational approach).
Another aspect of hemodynamic stabilization is the
maintenance of the “right” mean arterial pressure
(MAP). However, how do we know what the “right”
MAP is? The current sepsis guidelines recommend a
MAP of at least 65 mmHg within the first 6 hours [10].
Nevertheless, a “one size fits all” solution seems extre-
mely unlikely with respect to the heterogeneity of the
common patient collective. In this context, Asfar et al.
Figure 1 Decrease in control group mortality from 2001 to
2014. The decrease in mortality of the control groups from the
2001 Rivers et al. study [14] and the 2014 Australian Resuscitation In
Sepsis Evaluation study [16].
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performed a prospective clinical study investigating the
effects of different MAP levels on mortality and organ
dysfunction in patients suffering from septic shock.
Seven hundred and seventy-six patients were rando-
mized to receive therapy either with a MAP of
65-70 mmHg (low-target group) or 80-85 mmHg (high-
target group) [20]. The authors noticed no difference
between the groups regarding 28-day and 90-day mor-
tality. However, the patients in the high-target group
had a higher incidence of atrial fibrillation, and patients
suffering from chronic hypertension in the low-target
group received more renal replacement therapy [20].
Although the overall mortality among groups was simi-
lar, one should not conclude that the interventions were
without any effects.
Perhaps we have to be more careful to interpret data of
large trials and should unmask typical “large trial dis-
eases”. If no individual therapeutic targets are set and
achieved in a study, the overall outcome is unlikely to be
positive. The reason for this is that there may be patients
in each treatment arm who experience benefit, neutral
effects, or harm by the same intervention (Figure 2). As a
consequence, the overall effect will be interpreted as not
being different. It may thus be misleading to conclude
that the intervention per se is useless. The aim should
rather be to identify the subpopulations of patients who
experience harm or benefit due to the intervention and
to analyze why these effects occurred. This would provide
much more information than the simple conclusion that
there are no differences between the groups regarding
overall long-term mortality.
Taken together, the basic principles of fighting sepsis
are similar to the rules of preventing shark attacks: once
one is swimming in dangerous waters, high attention is
needed. However, if one has bad luck and a shark
approaches with the intention to attack, high speed may
be important to survive. Similarly, time is critical in
fighting septic shock. Obvious problems should there-
fore be fixed, and they should be fixed as soon as possi-
ble. In this regard, it makes human (physiologic) sense
that septic patients do benefit from early intervention
and treatment. This assumption is supported by the fact
that the awareness resulting from the Rivers et al. trial
[14] led to a rapid change in practice. Since it is logical
that time matters, early (goal-directed) treatment
became a global standard. To which degree this concept
contributed to the overall reduction in mortality rates of
sepsis during the last decade remains unanswered, but it
is most likely that it played a substantial role.
Avoidance and prevention of sepsis are undoubtedly
the best route for the patient. However, if the “predator”
is around you somewhere, be alert and prepared to act
as fast and effectively as possible so that you have a
chance to win the race against the “septic shark”.
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Rivers et al. (2001) [14] 30.5/46.5 33.3/49.2 44.3/56.9 N/A
ProCESS (2014) [15] N/A N/A 21.0/18.9 31.9/33.7
ARISE (2014) [16] N/A 14.8/14.9 N/A 18.6/18.8
ProMiSe (2015) [17] N/A 24.8/24.5 N/A 29.5/29.2
Data presented as EGDT/control
The term “control” is used synonymously for “standard care” (Rivers et al.) and “usual care” (ProCESS, ARISE, and ProMiSe studies)
ARISE Australian Resuscitation In Sepsis Evaluation, EGDT early goal-directed therapy, N/A not available, ProCESS Protocolized Care for Early Septic Shock, ProMiSe
Protocolized Management in Sepsis {AU Query: Confirm table. You forgot to mention that the fisrt number represents EGDT and the second control as described
in the original table}
Figure 2 “Large trial disease”.
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